TRAC Locus-inserted CD19-targeting STAR-T Cell Therapy in r/r B-NHL

Clinical trial NCT05631912 · UNKNOWN

Trial details

NCT number: NCT05631912
Sponsor: Chinese PLA General Hospital
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Non-hodgkin Lymphoma,B Cell

Start date: 2023-06-30
Primary completion: 2024-12-15
Enrollment: 38

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.